CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Should we prescribe carbapenem for treating febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in children with vesicoureteral reflux?
Ji Young Park
Clin Exp Pediatr. 2021;64(6):284-285.   Published online January 5, 2021
DOI: https://doi.org/10.3345/cep.2020.01830

Excel Download

Should we prescribe carbapenem for treating febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in children with vesicoureteral reflux?
Clinical and Experimental Pediatrics. 2021;64(6):284-285   Crossref logo
Link1 Link2 Link3

1472. Non-Carbapenems for Treating Community-Associated Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Children
Open Forum Infectious Diseases. 2019;6(Supplement_2):S537-S537   Crossref logo
Link1 Link2

Febrile urinary-tract infection due to extended-spectrum beta-lactamase–producing Enterobacteriaceae in children: A French prospective multicenter study
PLOS ONE. 2018;13(1):e0190910   Crossref logo
Link1

Isolation of extended spectrum beta-lactamase producing Enterobacteriaceae among children with urinary tract infection: A cross sectional study.
. 2020;   Crossref logo
Link1 Link2

A Clinical Prediction Tool for Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Urinary Tract Infection
. 2021;   Crossref logo
Link1 Link2

Non-carbapenem β-lactam/β-lactamase inhibitors versus carbapenems for urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae: a systematic review
International Journal of Antimicrobial Agents. 2021;58(4):106410   Crossref logo
Link1 Link2

Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae
Journal of Infection and Public Health. 2019;12(6):843-846   Crossref logo
Link1 Link2

Non-carbapenem therapy of urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae
Médecine et Maladies Infectieuses. 2015;45(5):169-172   Crossref logo
Link1 Link2

Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
Therapeutic Advances in Infectious Disease. 2019;6:204993611985888   Crossref logo
Link1 Link2 Link3

Risk of recurrence in children with a urinary tract infection due to extended‐spectrum beta‐lactamase‐producing Enterobacteriaceae
Acta Paediatrica. 2020;109(12):2808-2809   Crossref logo
Link1 Link2 Link3